Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q2 EPS by 55c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $74.52 +0.15%
Revenue Growth %: +89.6%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +89.6%
Financial Fact:
TOTAL OPERATING EXPENSES: 19.38M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($1.02), $0.55 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Schwab's May activity shows margin loans nearly double
- BIG3 Basketball to go public via Graf Global merger at $290 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
